Small Structures,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 19, 2025
To
effectively
address
crisis
emergence
of
new
virus
such
as
monkeypox,
a
collective
and
collaborative
effort
between
scientists,
engineers,
innovators,
artists
from
all
ages,
regions,
diverse
fields
is
required.
This
review
explores
holistic
approach
to
addressing
the
monkeypox
by
integrating
nanobiosensors,
artificial
intelligence,
visual
arts,
humanities,
social
sciences.
Traditional
diagnostic
methods
are
often
limited
time,
accessibility,
accuracy,
but
advancement
point‐of‐care
smart
nanobiosensors
offers
promising
shift
toward
rapid,
precise,
accessible
diagnostics.
They
enhance
ability
screen,
diagnose,
monitor
infections
efficiently,
contributing
better
disease
management.
Beyond
technological
innovation,
essential
role
sciences
in
fostering
public
engagement,
understanding,
acceptance
tools
emphasized.
Visual
arts
can
illustrate
scientific
concepts,
making
them
more
relatable,
while
storytelling
through
various
media
reduce
stigma
promote
preventive
measures.
Social
provide
insights
into
cultural
attitudes,
behaviors,
health
challenges,
ensuring
that
solutions
integrated
communities.
By
combining
these
disciplines,
this
presents
comprehensive
framework
for
resilient
global
system
aligns
with
One
Health
principles,
emphasizing
interconnectedness
human,
animal,
environmental
health.
Advanced Functional Materials,
Journal Year:
2024,
Volume and Issue:
34(38)
Published: April 23, 2024
Abstract
Currently,
microbial
infections
have
posed
an
arduous
challenge
to
global
public
health,
whereas
the
rise
of
antibiotic
resistance
is
rendering
traditional
therapies
futile,
prompting
development
new
antimicrobial
technologies.
Photoactive
nanomaterials
thus
garnered
a
thriving
interest
for
disinfection
owing
their
superior
antibacterial
efficaciousness,
favorable
biosafety,
and
rapidness
spatiotemporal
precision
in
excreting
bactericidal
actions.
The
review
summarizes
recent
advances
emerging
trends
design,
nanoengineering,
bioapplications
photoactive
antimicrobials.
It
commences
by
elaborating
fundamental
theories
on
bacterial
resistance,
mechanisms
phototherapy.
Subsequently,
regulation
effectiveness
comprehensively
discussed,
centering
criteria
strategies
tuning
photoabsorption
spectra,
photothermal
conversion,
photocatalytic
efficiency,
alongside
tactics
enabling
synergistic
therapies.
This
followed
comparative
analyses
techniques
modalities
synthesizing
engineering
with
diverse
structures,
forms,
functionalities.
Thereafter,
state‐of‐the‐art
applications
phototherapies
across
various
medical
sectors
are
portrayed,
key
challenges
opportunities
finally
discussed
spur
future
innovations
translation.
envisaged
provide
useful
guidance
devising
developing
nanomaterials‐based
photoresponsive
antimicrobials
application‐specific
materials
properties
biological
functions.
Acta Pharmaceutica Sinica B,
Journal Year:
2024,
Volume and Issue:
14(11), P. 4683 - 4716
Published: Sept. 2, 2024
About
40%
of
approved
drugs
and
nearly
90%
drug
candidates
are
poorly
water-soluble
drugs.
Low
solubility
reduces
the
drugability.
Effectively
improving
bioavailability
is
a
critical
issue
that
needs
to
be
urgently
addressed
in
development
application.
This
review
briefly
introduces
conventional
solubilization
techniques
such
as
solubilizers,
hydrotropes,
cosolvents,
prodrugs,
salt
modification,
micronization,
cyclodextrin
inclusion,
solid
dispersions,
details
crystallization
strategies,
ionic
liquids,
polymer-based,
lipid-based,
inorganic-based
carriers
bioavailability.
Some
most
commonly
used
carrier
materials
for
presented.
Several
using
summarized.
Furthermore,
this
summarizes
mechanism
each
technique,
reviews
latest
research
advances
challenges,
evaluates
potential
clinical
translation.
could
guide
selection
approach,
dosage
form,
administration
route
Moreover,
we
discuss
several
promising
attracting
increasing
attention
worldwide.
Frontiers in Medicine,
Journal Year:
2025,
Volume and Issue:
12
Published: Jan. 22, 2025
Parkinson’s
disease
is
a
progressive
neurodegenerative
that
destroys
substantia
nigra
dopaminergic
neurons,
causing
tremors,
bradykinesia,
rigidity,
and
postural
instability.
Current
treatment
approaches
primarily
focus
on
symptom
management,
employing
pharmacological,
non-pharmacological,
surgical
methods.
However,
these
treatments
often
result
in
fluctuating
symptoms,
side
effects,
progression.
Here,
the
authors
have
reviewed
emerging
field
of
nanomedicine
as
promising
path
for
treatment,
emphasizing
its
potential
to
overcome
limitations
traditional
therapies.
Nanomedicine
utilizes
nanoparticles
targeted
drug
delivery,
leveraging
their
small
size
high
surface
area
volume
ratio
cross
blood-brain
barrier
deliver
therapeutic
agents
directly
affected
brain
regions.
Various
nanoparticles,
including
lipid-based,
polymeric,
metallic,
carbon-based,
shown
treatment.
Additionally,
nanocarrier
systems
like
liposomes,
nanogels,
dendrimers,
solid
lipid
offer
controlled
sustained
release
agents,
enhancing
bioavailability
reducing
effects.
This
review
provides
insights
into
pathophysiology
disease,
highlighting
mechanisms
neurodegeneration,
role
alpha-synuclein,
disruption
pathways.
It
further
discusses
application
gene
therapy
conjunction
with
interventions.
Journal of Functional Biomaterials,
Journal Year:
2025,
Volume and Issue:
16(1), P. 24 - 24
Published: Jan. 14, 2025
Autoimmune
diseases
present
complex
therapeutic
challenges
due
to
their
chronic
nature,
systemic
impact,
and
requirement
for
precise
immunomodulation
avoid
adverse
side
effects.
Recent
advancements
in
biodegradable
stimuli-responsive
nanomaterials
have
opened
new
avenues
targeted
drug
delivery
systems
capable
of
addressing
these
challenges.
This
review
provides
a
comprehensive
analysis
state-of-the-art
nanocarriers
such
as
polymeric
nanoparticles,
liposomes,
hydrogels
engineered
autoimmune
therapies.
These
are
designed
degrade
safely
the
body
while
releasing
agents
response
specific
stimuli,
including
pH,
temperature,
redox
conditions,
enzymatic
activity.
By
achieving
localized
controlled
release
anti-inflammatory
immunosuppressive
agents,
minimize
toxicity
enhance
efficacy.
We
discuss
underlying
mechanisms
nanomaterials,
recent
applications
treating
rheumatoid
arthritis,
multiple
sclerosis,
inflammatory
bowel
disease,
design
considerations
essential
clinical
translation.
Additionally,
we
address
current
challenges,
biocompatibility,
scalability,
regulatory
hurdles,
well
future
directions
integrating
advanced
nanotechnology
with
personalized
medicine
treatment.
highlights
transformative
potential
presenting
them
promising
strategy
advance
precision
improve
patient
outcomes
disease
management.
Chemistry of Materials,
Journal Year:
2024,
Volume and Issue:
36(9), P. 4054 - 4077
Published: April 18, 2024
Stimuli-responsive
self-immolative
polymers
(SIPs)
represent
a
unique
class
of
that
can
undergo
controlled,
sequential
head-to-tail
depolymerization
upon
specific
stimuli.
Since
their
inception,
they
have
evolved
over
two
decades
to
become
one
the
most
attractive
polymer
types.
With
characteristic
feature
"one
stimulus,
multiple
responses",
SIPs
inherently
possess
ability
serve
as
chemical
amplifiers,
which
amplify
weak
or
biological
signals.
This
promises
higher
stimulus
sensitivity,
greater
selectivity
for
microenvironments,
and
potential
generate
more
persistent,
extensive,
significant
responses
while
consuming
fewer
stimuli
sources.
Review
summarizes
latest
research
advancements
in
stimuli-responsive
drug
delivery
molecular
imaging
past
five
years.
Regarding
structure
SIPs,
we
briefly
overview
updates
self-immolation
units,
end-cap
moieties,
sequence
SIPs.
In
terms
applications,
focus
on
possible
applications
disease
treatment
methods.
Finally,
provide
brief
perspective
future
directions
these
applications.
Nanoscale,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 1, 2025
Gene
and
RNA-based
therapeutics
represent
a
promising
frontier
in
oncology,
enabling
targeted
modulation
of
tumor-associated
genes
proteins.
This
review
explores
the
latest
advances
payload
vectorization
delivery
systems
developed
for
vivo
cancer
treatments.
We
discuss
viral
non-viral
organic
particles,
including
lipid
based
nanoparticles
polymeric
structures,
effective
transport
plasmids,
siRNA,
self-amplifying
RNA
therapeutics.
Their
physicochemical
properties,
strategies
to
overcome
intracellular
barriers,
innovations
cell-based
carriers
engineered
extracellular
vesicles
are
highlighted.
Moreover,
we
consider
oncolytic
viruses,
novel
capsid
modifications,
approaches
that
refine
tumor
targeting
immunomodulation.
Ongoing
clinical
trials
regulatory
frameworks
guide
future
directions
emphasize
need
safe,
scalable
production.
The
potential
convergence
these
with
combination
therapies
paves
way
toward
personalized
medicine.
Advanced Healthcare Materials,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 10, 2025
Abstract
Gene
therapy
offers
transformative
potential
for
treating
genetic
disorders
by
directly
addressing
the
molecular
root
causes
of
diseases.
However,
primary
challenges
gene
involve
efficient
delivery
therapeutic
material
to
target
cells,
crossing
biological
barriers,
managing
toxicity
and
immune
responses.
Mesoporous
silica
nanoparticles
(MSNs),
due
their
unique
structural
features
have
emerged
as
a
promising
platform
overcome
these
challenges.
In
recent
years,
MSNs
gained
significant
attention
nanocarriers
various
nucleic
acids.
This
review
comprehensively
examines
role
in
therapy,
focusing
on
capabilities
targeted
siRNA,
DNA,
CRISPR‐Cas
systems,
other
therapeutics.
work
explores
modern
advancements
synthesis
functionalization
strategies
impact
modifications
stability,
cellular
uptake,
controlled
release
under
physiological
conditions.
Additionally,
highlights
use
develop
theranostic
where
is
combined
with
diagnostic
imaging
real‐time
monitoring
personalized
treatment
strategies.
Finally,
this
discusses
future
perspectives
delivery,
regulatory
challenges,
enhancing
clinical
translation,
expanding
application
cancers.